Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1132614

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1132614

U.S. Sleep Disorder Clinics Market - Industry Outlook & Forecast 2022-2027

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3500
PDF (5 User License)
USD 3995
PDF (Corporate User License)
USD 4995

Add to Cart

The U.S. sleep disorder clinics market is expected to grow at a CAGR of 5.01% during 2022-2027.

MARKET SYNOPSIS

a) One in three Americans reports insufficient sleep every night. Sleep disorders remain underdiagnosed, and some people experience restless nights. A few nights of toss and turns can be due to stress or changes in daily life, but the inability to fall asleep or sleep for long periods indicates a need to visit a sleep clinic. Problems such as falling and staying asleep, snoring, choking, and gasping during sleep can be painful. Understanding what a sleep clinic is and what happens there can help with diagnosis and treatment. These elements have contributed to the expansion of the U.S. sleep disorder clinics market and the growth of the sleep market.

b) Sleep center and sleep clinic are terms that are used interchangeably. Both terms refer to the medical field where sleep tests are performed. Some sleep laboratories are dedicated to testing, while others provide testing along with outpatient treatment for people with insomnia. Sleep clinics can help people diagnose sleep disorders and sleep problems. The sleep clinic can diagnose common sleep disorders such as obstructive sleep apnea, insomnia, and narcolepsy.

c) The Sleep lab services are of three distinct types: sleep facility, sleep clinic, and sleep labs. The sleep facility contains a clinic for evaluating patients and a laboratory for diagnosing patients. A sleep clinic is an outpatient facility where patients can visit, get diagnosed, and receive treatment for their sleep conditions. Sleep labs, on the other hand, are where the diagnosis of sleep disorder is performed. It can be in-lab testing or house sleep testing.

d) On the other hand, home sleep testing is only helpful in diagnosing sleep apnea testing. HST is only prescribed when the physician ensures that the patient suffers from obstructive sleep apnea. It is not recommended for other sleep disorders. Along with the analysis of night sleep, sleep lab services also perform day sleep studies. Technologies such as actigraphy, multiple sleep latency tests, PAP therapy, and home sleep studies are used for day sleep studies. Actigraphy involves using a wearable sleep monitor to address a person's sleep pattern. Multiple Sleep Latency Test addresses sleep patterns after an overnight sleep study. PAP therapy is used to train the patient to use the PAP machine for sleep apnea management and to make them comfortable with its use.

e) With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography is the most preferred technology for diagnosis. With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs.

MARKET TRENDS & OPPORTUNITIES

Shift Towards The Home-Based Care Model

The sleep apnea studies have been shifting to the home for many years. And the trend has only enhanced during the pandemic. According to EnsoData's survey, pre-COVID volumes were 70% in-lab and 30% home sleep testing (HST), which found this in-lab to home testing ratio flipped during the pandemic. The significant reduction in sleep center activity due to COVID-19 has most definitely accelerated the adoption of online consultations, remote patient care, and starting and dispatch of home sleep apnea testing (HSAT) technologies utilizing home delivery by the sleep centers.

Cloud-Based Diagnostic Platforms for Sleep Disorder Professionals

Cloud computing offers sleep professionals access to real-time patient data from anywhere with access to the internet. From CPAP compliance to managing continuity of care, these software solutions are ready to simplify the lives of providers and patients. A growing number of CPAP and clinic management software providers are switching to cloud-based systems to make sleep medicine practices more efficient and successful.

The primary goals of ubiquitous computing in sleep tracking are sensor miniaturization and non-invasive sensing that can comprehensively monitor the physiological signals associated with sleep activity.

  • Growing Prevalence of Sleep Disorders

The prevalence of sleep disorders differs widely depending on the individual study and disorder. However, the majority of sleep disorders among the population is 20-40%. The prevalence of sleep disorders in the US follows a similar pattern, affecting 50 to 70 million adults in the US. According to sleep deprivation statistics, about 35% of adults in the US report less than 7 hours of sleep in the normal 24 hours.

  • Sleep deprivation data show that men and women are equally affected. Recent studies of US veterans highlight the prevalence of sleep disorders. A survey conducted in 2021 by the Journal of Clinical Sleep Medicine reported that undiagnosed, poorly treated sleep disorders are common in veterans at risk for cardiovascular disease. In a sample of 420 veterans, more than half (52.1%) were positive for sleep apnea. In addition to the high prevalence of sleep apnea, many veterans also experience insomnia.

Increasing Awareness of Sleep Disorders

The AAHS aims to promote healthy sleep and improve the lives of people with sleep disorders. Membership connects patients and health care providers in a partnership to enhance sleep health for all. The American Alliance for Healthy Sleep collaborates with patients, providers, and others interested in promoting healthy sleep. These promotional activities target the population and medical specialists. Such as pulmonologists, sleep medicine specialists, primary care physicians, cardiologists, neurologists, and other medical subspecialists treating these conditions and their associated comorbidities.

TELEHEALTH IN SLEEP DISORDER PRACTICES

  • A nationwide shortage of medical specialists coupled with a tech-savvy patient population is an opportunity for advances in health care access. Because sleep medicine is not a procedure-based specialty, this field holds special promise for telehealth-based approaches.
  • Sleep telehealth has already been evaluated in several settings and has promise for remote care. For sleep-disordered breathing, computer-based cognitive behavioral therapy for insomnia (CBT-I), home sleep testing, actigraphy, commercial wearables, and modem-enabled continuous positive airway pressure devices provide a robust platform for effective sleep telehealth. Given the advancing digital technologies, remote sleep technologies will move faster than earlier innovations in medical care that have impacted training programs. Today, the consumer obsession with self-monitoring activities such as fitness trackers and sleep is fostering innovation at an exponentially faster pace, with personal proprietary data for which patients look to their health providers for validation.

NEWLY DISCOVERED SLEEP TESTING BEST PRACTICES

  • The COVID-19 crisis disproportionally affected sleep centers that relied exclusively on in-lab testing, with 72% suspending operations during the pandemic. In some cases, 79% of sleep centers that offer HSTs maintained some or all home testing volumes during the crisis.
  • In 48% of cases, respondents reported increased demand or additional technology investment to meet HST demand.
  • Sleep centers (64%), which offer telemedicine consultation and booking options, outperform sleep centers (36%), which do not provide these technical services.
  • Patient care from diagnosis to treatment and management; can now be processed in a virtual environment.

SEGMENTATION ANALYSIS

  • The affiliated clinic segment accounts for a significant share by ownership analysis in the U.S. sleep disorder clinics market and anticipates retaining its market dominance during the forecast period. The industry segments into independent and affiliated clinics. The increasing prevalence of sleep disorders drives the demand for sleep disorder clinics in the United States.
  • Based on applications, the sleep disorder clinics market in the U.S. segments into sleep testing, PAP therapy, consultation, and others. The sleep testing segment accounts for a major share of the industry.
  • Over 80 sleep disorders affect human life in some form, diminishing its quality. Sleep disorders can affect not only the physical health but also the mental health of a person. Hence, diagnosing and treating sleep disorders is crucial, avoiding the chances of other chronic conditions that may progress because of sleep disorders. Such factors have initiated the demand for sleep disorder clinics in the U.S.
  • Based on the payor, the sleep disorder clinics market in the US segments into private health insurance, public health insurance, and out-of-pocket. The private health insurance segment accounted for a significant share of 52.15% in 2021. The Private health insurance segment is anticipated to retain its market dominance during the forecast period. The public health insurance segment projects to register a CAGR of 5.13% during the forecast period 2021-2027.

Segmentation by Ownership

  • Affiliated Clinics
  • Independent Clinics

Segmentation by Applications

  • Sleep Testing
  • PAP Therapy
  • Consultation
  • Others

Segmentation by Payor

  • Private Health Insurance
  • Public Health Insurance
  • Out-of-Pocket

GEOGRAPHICAL INSIGHTS

The geographic distribution of sleep disorders in the U.S. is uneven. Some areas experience disproportionately high amounts of insufficient sleep, which has become an essential public health issue. On the basics of the region, the U.S. sleep disorder clinics market segments into East, West, South, and Midwest. The East region accounts for a significant stake in 2021.

The states in the East have the highest prevalence of sleep disorders as the people there suffer from limited sleeping hours. The sleep disorder clinics market in this region gets a boost by factors like prolonged usage of digital gadgets like mobile phones, a high number of advanced streetlights, and an increase in light pollution, which increases the use of lights at night.

Segmentation by Region

  • The U.S.
    • Southern US
    • Western US
    • Midwest US
    • Eastern US

KEY INDUSTRY PLAYERS

The U.S. sleep disorder clinics market witnesses a moderate threat of new entrants. The country reports a significant number of clinics in the market and an increasing prevalence of sleep disorders, raising the demand for diagnosis and treatment. Though there is high demand for sleep diagnosis services, there is less competition among the players in the market. The clinics in the market face competition from a range of other companies that specialize in delivering services that offer easy access to sleep disorder management.

Few players in the market like SleepMed, SleepWorks, and Comprehensive Sleep Care have a chain of labs and perform a large volume of sleep studies. Many hospitals affiliated clinics and large multispecialty hospitals have sleep labs as a part of their consultation. There is a massive increase in patients suffering from sleep disorders, pressuring hospitals to develop more sleep study centers. The key companies are investing mainly in mergers and acquisitions. One of the significant acquisitions is that SleepMed acquired one of the US's largest home sleep study providers.

Key Vendors

  • Comprehensive Sleep Care
  • SleepMed
  • SleepWorks

Other Prominent Vendors

  • Advantage Sleep Centers
  • Anchorage Sleep Center
  • AU Health
  • Butler Health System
  • Clark Memorial Health
  • Clayton Sleep Institute
  • Cleveland Clinic
  • Englewood Health
  • Grand View Health
  • Hunterdon Health
  • Intermountain Healthcare
  • Jupiter Medical Center
  • Koala Centers for Sleep & TMJ Disorders
  • Mayo Clinic
  • Nationwide Children's Hospital
  • Penn Medicine
  • Sleep Center of Nevada
  • Sleep Medicine Associates of Texas
  • Somerset Pulmonary and Sleep Medicine Center
  • Stanford Health Care
  • Center for Sleep Medicine
  • Thomas Jefferson University Hospitals
  • UAB Health System
  • UCLA Health
  • University of Illinois Hospital & Health Sciences System
  • USA Sleep Diagnostic Services
  • Valley Health System
  • Weill Cornell Medicine

KEY QUESTIONS ANSWERED

  • 1. What is the growth rate of the U.S. sleep disorder clinics market?
  • 2. What is the estimated U.S. sleep disorder clinics market share by 2027?
  • 3. Who are the leading players in the U.S. sleep disorder clinics market?
  • 4. What are the factors driving the U.S. sleep disorder clinics market?
  • 5. Which region in the U.S. is leading the U.S. sleep disorder clinics market?
Product Code: ARZ220728

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 OWNERSHIP SEGMENTATION
    • 4.3.2 APPLICATIONS SEGMENTATION
    • 4.3.3 PAYOR SEGMENTATION

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

8 INTRODUCTION

  • 8.1 OVERVIEW
  • 8.2 ROLE OF TELEMEDICINE IN MITIGATING SLEEP DISORDERS
    • 8.2.1 TELEMEDICINE ADOPTION AMONG US PHYSICIANS

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 USE OF ADVANCED TECHNOLOGIES TO ADDRESS SLEEP-LOSS EPIDEMIC
  • 9.2 SHIFT TOWARD HOME-BASED CARE MODEL
  • 9.3 ADOPTION OF CLOUD-BASED SOLUTIONS FOR SLEEP DISORDER MANAGEMENT

10 MARKET GROWTH ENABLERS

  • 10.1 SURGE IN PREVALENCE OF SLEEP DISORDERS
  • 10.2 ECONOMIC BURDEN OF SLEEP DISORDERS
  • 10.3 RISE IN AWARENESS OF SLEEP DISORDERS

11 MARKET RESTRAINTS

  • 11.1 SHORTAGE OF PEDIATRIC SLEEP LABORATORIES
  • 11.2 COVID-19 & IMPLICATIONS ON SLEEP MEDICINE
  • 11.3 FRAUDULENT BILLING PRACTICES BY SLEEP STUDY CLINICS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 OWNERSHIP INSIGHTS
    • 12.2.2 APPLICATIONS INSIGHTS
    • 12.2.3 PAYOR INSIGHTS
    • 12.2.4 REGION INSIGHTS
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 THREAT OF RIVALRY

13 OWNERSHIP

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 AFFILIATED CLINICS
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
  • 13.4 INDEPENDENT CLINICS
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST

14 APPLICATION

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 SLEEP TESTING
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
  • 14.4 PAP THERAPY
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
  • 14.5 CONSULTATION
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
  • 14.6 OTHERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST

15 PAYOR

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 PRIVATE HEALTH INSURANCE
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
  • 15.4 PUBLIC HEALTH INSURANCE
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
  • 15.5 OUT-OF-POCKET
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST

16 REGION

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 EAST
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
  • 16.4 SOUTH
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 WEST
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 MIDWEST
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST

17 COMPETITIVE LANDSCAPE

  • 17.1 COMPETITION OVERVIEW
  • 17.2 MARKET SHARE ANALYSIS
    • 17.2.1 COMPREHENSIVE SLEEP CARE
    • 17.2.2 SLEEPMED
    • 17.2.3 SLEEPWORKS

18 KEY COMPANY PROFILES

  • 18.1 COMPREHENSIVE SLEEP CARE
    • 18.1.1 BUSINESS OVERVIEW
    • 18.1.2 KEY STRATEGIES
    • 18.1.3 KEY STRENGTHS
    • 18.1.4 KEY OPPORTUNITIES
  • 18.2 SLEEPMED
    • 18.2.1 BUSINESS OVERVIEW
    • 18.2.2 KEY STRATEGIES
    • 18.2.3 KEY STRENGTHS
    • 18.2.4 KEY OPPORTUNITIES
  • 18.3 SLEEPWORKS
    • 18.3.1 BUSINESS OVERVIEW
    • 18.3.2 KEY STRATEGIES
    • 18.3.3 KEY STRENGTHS
    • 18.3.4 KEY OPPORTUNITIES

19 OTHER PROMINENT VENDORS

  • 19.1 ADVANTAGE SLEEP CENTERS
    • 19.1.1 BUSINESS OVERVIEW
  • 19.2 ANCHORAGE SLEEP CENTER
    • 19.2.1 BUSINESS OVERVIEW
  • 19.3 AU HEALTH
    • 19.3.1 BUSINESS OVERVIEW
  • 19.4 BUTLER HEALTH SYSTEM
    • 19.4.1 BUSINESS OVERVIEW
  • 19.5 CLARK MEMORIAL HEALTH
    • 19.5.1 BUSINESS OVERVIEW
  • 19.6 CLAYTON SLEEP INSTITUTE
    • 19.6.1 BUSINESS OVERVIEW
  • 19.7 CLEVELAND CLINIC
    • 19.7.1 BUSINESS OVERVIEW
  • 19.8 ENGLEWOOD HEALTH
    • 19.8.1 BUSINESS OVERVIEW
  • 19.9 GRAND VIEW HEALTH
    • 19.9.1 BUSINESS OVERVIEW
  • 19.10 HUNTERDON HEALTH
    • 19.10.1 BUSINESS OVERVIEW
  • 19.11 INTERMOUNTAIN HEALTHCARE
    • 19.11.1 BUSINESS OVERVIEW
  • 19.12 JUPITER MEDICAL CENTER
    • 19.12.1 BUSINESS OVERVIEW
  • 19.13 KOALA CENTER FOR SLEEP & TMJ DISORDERS
    • 19.13.1 BUSINESS OVERVIEW
  • 19.14 MAYO CLINIC
    • 19.14.1 BUSINESS OVERVIEW
  • 19.15 NATIONWIDE CHILDREN'S HOSPITAL
    • 19.15.1 BUSINESS OVERVIEW
  • 19.16 PENN MEDICINE
    • 19.16.1 BUSINESS OVERVIEW
  • 19.17 SLEEP CENTER OF NEVADA
    • 19.17.1 BUSINESS OVERVIEW
  • 19.18 SLEEP MEDICINE ASSOCIATES OF TEXAS
    • 19.18.1 BUSINESS OVERVIEW
  • 19.19 SOMERSET PULMONARY AND SLEEP MEDICINE CENTER
    • 19.19.1 BUSINESS OVERVIEW
  • 19.20 STANFORD HEALTH CARE
    • 19.20.1 BUSINESS OVERVIEW
  • 19.21 CENTER FOR SLEEP MEDICINE
    • 19.21.1 BUSINESS OVERVIEW
  • 19.22 THOMAS JEFFERSON UNIVERSITY HOSPITALS
    • 19.22.1 BUSINESS OVERVIEW
  • 19.23 UAB HEALTH SYSTEM
    • 19.23.1 BUSINESS OVERVIEW
  • 19.24 UCLA HEALTH
    • 19.24.1 BUSINESS OVERVIEW
  • 19.25 UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM
    • 19.25.1 BUSINESS OVERVIEW
  • 19.26 USA SLEEP DIAGNOSTIC SERVICES
    • 19.26.1 BUSINESS OVERVIEW
  • 19.27 VALLEY HEALTH SYSTEM
    • 19.27.1 BUSINESS OVERVIEW
  • 19.28 WEILL CORNELL MEDICINE
    • 19.28.1 BUSINESS OVERVIEW

20 REPORT SUMMARY

  • 20.1 KEY TAKEAWAYS
  • 20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

  • 21.1 MARKET BY OWNERSHIP
  • 21.2 MARKET BY APPLICATIONS
  • 21.3 MARKET BY PAYOR
  • 21.4 MARKET BY REGION

22 APPENDIX

  • 22.1 ABBREVATIONS
Product Code: ARZ220728

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF US SLEEP DISORDER CLINICS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 US SLEEP DISORDER CLINICS MARKET: GROWTH RATE 2022-2027 (%)
  • EXHIBIT 4 IMPACT OF USE OF ADVANCED TECHNOLOGIES TO ADDRESS SLEEP-LOSS EPIDEMIC
  • EXHIBIT 5 IMPACT OF SHIFT TOWARD HOME-BASED CARE MODEL
  • EXHIBIT 6 IMPACT OF ADOPTION OF AI & CLOUD-BASED SOLUTIONS FOR SLEEP DISORDER MANAGEMENT
  • EXHIBIT 7 EMERGING SLEEP SENSING TECHNOLOGIES
  • EXHIBIT 8 IMPACT OF SURGE IN PREVALENCE OF SLEEP DISORDERS
  • EXHIBIT 9 IMPACT OF ECONOMIC BURDEN OF SLEEP DISORDERS
  • EXHIBIT 10 IMPACT OF RISE IN AWARENESS OF SLEEP DISORDERS
  • EXHIBIT 11 ADDRESSING FOLLOWING ISSUES IMPROVE ACCESS TO SLEEP CARE
  • EXHIBIT 12 IMPACT OF SHORTAGE OF PEDIATRIC SLEEP LABORATORIES
  • EXHIBIT 13 IMPACT OF COVID-19 & IMPLICATIONS ON SLEEP MEDICINE
  • EXHIBIT 14 IMPACT OF FRAUDULENT BILLING PRACTICES BY SLEEP STUDY CLINICS
  • EXHIBIT 15 US SLEEP DISORDER CLINICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 16 US SLEEP DISORDER CLINICS MARKET SHARE BY OWNERSHIP
  • EXHIBIT 17 US SLEEP DISORDER CLINICS MARKET SHARE BY APPLICATION
  • EXHIBIT 18 US SLEEP DISORDER CLINICS MARKET SHARE BY PAYOR
  • EXHIBIT 19 US SLEEP DISORDER CLINICS MARKET BY REGION
  • EXHIBIT 20 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 21 INCREMENTAL GROWTH BY OWNERSHIP 2021 & 2027
  • EXHIBIT 22 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP: INCREMENTAL GROWTH
  • EXHIBIT 23 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP: ABSOLUTE GROWTH
  • EXHIBIT 24 PROS AND CONS OF AFFILIATED SLEEP CLINICS
  • EXHIBIT 25 US SLEEP DISORDER CLINICS MARKET BY AFFILIATED CLINICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 26 US SLEEP DISORDER CLINICS MARKET BY AFFILIATED CLINICS 2021-2027 ($ BILLION)
  • EXHIBIT 27 PROS AND CONS OF INDEPENDENT SLEEP CLINICS
  • EXHIBIT 28 US SLEEP DISORDER CLINICS MARKET BY INDEPENDENT CLINICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 29 US SLEEP DISORDER CLINICS MARKET IN BY INDEPENDENT CLINICS 2021-2027 ($ BILLION)
  • EXHIBIT 30 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 31 US SLEEP DISORDER CLINICS MARKET BY APPLICATION: INCREMENTAL GROWTH
  • EXHIBIT 32 US SLEEP DISORDER CLINICS MARKET BY APPLICATION: ABSOLUTE GROWTH
  • EXHIBIT 33 OTHER TESTS FOR SLEEP APNEA
  • EXHIBIT 34 US SLEEP DISORDER CLINICS MARKET BY SLEEP TESTING: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 35 US SLEEP DISORDER CLINICS MARKET BY SLEEP TESTING 2021-2027 ($ BILLION)
  • EXHIBIT 36 US SLEEP DISORDER CLINICS MARKET BY PAP THERAPY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 37 US SLEEP DISORDER CLINICS MARKET BY PAP THERAPY 2021-2027 ($ BILLION)
  • EXHIBIT 38 US SLEEP DISORDER CLINICS MARKET BY CONSULTATION: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 39 BENEFITS OF TELECONSULTATION
  • EXHIBIT 40 US SLEEP DISORDER CLINICS MARKET BY CONSULTATION 2021-2027 ($ BILLION)
  • EXHIBIT 41 US SLEEP DISORDER CLINICS MARKET BY OTHER APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 42 US SLEEP DISORDER CLINICS MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 43 INCREMENTAL GROWTH BY PAYOR 2021 & 2027
  • EXHIBIT 44 US HEALTH CONSUMPTION EXPENDITURES BY TYPE 2020 ($ BILLION)
  • EXHIBIT 45 US SLEEP DISORDER CLINICS MARKET BY PAYOR: INCREMENTAL GROWTH
  • EXHIBIT 46 US SLEEP DISORDER CLINICS MARKET BY PAYOR: ABSOLUTE GROWTH
  • EXHIBIT 47 US SLEEP DISORDER CLINICS MARKET BY PRIVATE HEALTH INSURANCE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 US SLEEP DISORDER CLINICS MARKET BY PRIVATE HEALTH INSURANCE 2021-2027 ($ BILLION)
  • EXHIBIT 49 US SLEEP DISORDER CLINICS MARKET BY PUBLIC HEALTH INSURANCE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 50 US SLEEP DISORDER CLINICS MARKET BY PUBLIC HEALTH INSURANCE 2021-2027 ($ BILLION)
  • EXHIBIT 51 US SLEEP DISORDER CLINICS MARKET BY OUT-OF-POCKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 US SLEEP DISORDER CLINICS MARKET BY OUT-OF-POCKET 2021-2027 ($ BILLION)
  • EXHIBIT 53 INCREMENTAL GROWTH BY REGION 2021 & 2027
  • EXHIBIT 54 US SLEEP DISORDER CLINICS MARKET BY REGION: INCREMENTAL GROWTH
  • EXHIBIT 55 US SLEEP DISORDER CLINICS MARKET BY REGION: ABSOLUTE GROWTH
  • EXHIBIT 56 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW YORK (%)
  • EXHIBIT 57 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN PENNSYLVANIA (%)
  • EXHIBIT 58 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW JERSEY (%)
  • EXHIBIT 59 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW HAMPSHIRE (%)
  • EXHIBIT 60 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MASSACHUSETTS (%)
  • EXHIBIT 61 EAST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 62 EAST US SLEEP DISORDER CLINICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 63 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ALABAMA (%)
  • EXHIBIT 64 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN FLORIDA (%)
  • EXHIBIT 65 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MISSISSIPPI (%)
  • EXHIBIT 66 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN TEXAS (%)
  • EXHIBIT 67 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN GEORGIA (%)
  • EXHIBIT 68 SOUTH US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 69 SOUTH US SLEEP DISORDER CLINICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 70 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ARIZONA (%)
  • EXHIBIT 71 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEVADA (%)
  • EXHIBIT 72 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN WASHINGTON (%)
  • EXHIBIT 73 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW MEXICO (%)
  • EXHIBIT 74 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN CALIFORNIA (%)
  • EXHIBIT 75 WEST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 76 WEST US SLEEP DISORDER CLINICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 77 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MISSOURI (%)
  • EXHIBIT 78 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN INDIANA (%)
  • EXHIBIT 79 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ILLINOIS (%)
  • EXHIBIT 80 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NORTH DAKOTA (%)
  • EXHIBIT 81 MIDWEST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 82 MIDWEST US SLEEP DISORDER CLINICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 83 VENDORS IN US SLEEP DISORDER CLINICS MARKET: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 84 US SLEEP DISORDER CLINICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 REQUIRED NUMBER OF AVERAGE SLEEPING HOURS (BY AGE)
  • TABLE 4 RISK OF CHRONIC HEALTH CONDITIONS DUE TO SLEEP DEPRIVATION
  • TABLE 5 SLEEP STUDIES COVERED BY MEDICARE
  • TABLE 6 PREVALENCE OF SHORT SLEEP DURATION IN NEW YORK (BY AGE)
  • TABLE 7 PREVALENCE OF SHORT SLEEP DURATION IN PENNSYLVANIA (BY AGE)
  • TABLE 8 PREVALENCE OF SHORT SLEEP DURATION IN NEW JERSEY (BY AGE)
  • TABLE 9 PREVALENCE OF SHORT SLEEP DURATION IN NEW HAMPSHIRE (BY AGE)
  • TABLE 10 PREVALENCE OF SHORT SLEEP DURATION IN MASSACHUSETTS (BY AGE)
  • TABLE 11 PREVALENCE OF SHORT SLEEP DURATION IN ALABAMA (BY AGE)
  • TABLE 12 PREVALENCE OF INADEQUATE SLEEP DURATION IN FLORIDA (BY AGE)
  • TABLE 13 PREVALENCE OF SHORT SLEEP DURATION IN MISSISSIPPI (BY AGE)
  • TABLE 14 PREVALENCE OF SHORT SLEEP DURATION IN TEXAS (BY AGE)
  • TABLE 15 PREVALENCE OF SHORT SLEEP DURATION IN GEORGIA (BY AGE)
  • TABLE 16 PREVALENCE OF SHORT SLEEP DURATION IN ARIZONA (BY AGE)
  • TABLE 17 PREVALENCE OF SHORT SLEEP DURATION IN NEVADA (BY AGE)
  • TABLE 18 PREVALENCE OF SHORT SLEEP DURATION IN WASHINGTON (BY AGE)
  • TABLE 19 PREVALENCE OF SHORT SLEEP DURATION IN NEW MEXICO (BY AGE)
  • TABLE 20 PREVALENCE OF SHORT SLEEP DURATION IN CALIFORNIA (BY AGE)
  • TABLE 21 PREVALENCE OF SHORT SLEEP DURATION IN MISSOURI (BY AGE)
  • TABLE 22 PREVALENCE OF SHORT SLEEP DURATION IN INDIANA (BY AGE)
  • TABLE 23 PREVALENCE OF SHORT SLEEP DURATION IN ILLINOIS (BY AGE)
  • TABLE 24 PREVALENCE OF SHORT SLEEP DURATION IN NORTH DAKOTA (BY AGE)
  • TABLE 25 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP 2021-2027 ($ BILLION)
  • TABLE 26 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP 2021-2027 ($ BILLION)
  • TABLE 27 US SLEEP DISORDER CLINICS MARKET BY APPLICATIONS 2021-2027 ($ BILLION)
  • TABLE 28 US SLEEP DISORDER CLINICS MARKET BY APPLICATIONS 2021-2027 (%)
  • TABLE 29 US SLEEP DISORDER CLINICS MARKET BY PAYOR 2021-2027 ($ BILLION)
  • TABLE 30 US SLEEP DISORDER CLINICS MARKET BY PAYOR 2021-2027 (%)
  • TABLE 31 US SLEEP DISORDER CLINICS MARKET BY REGION 2021-2027 ($ BILLION)
  • TABLE 32 US SLEEP DISORDER CLINICS MARKET BY REGION 2021-2027 (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!